BioSpace News Archive

Evogene Ltd. today reported the receipt of a formal notification from The Nasdaq Stock Market LLC (" Nasdaq ") that the Company has regained compliance with Listing Rule 5450(a)(1), which requires the Company’s ordinary shares to maintain a minimum bid price of $1.00 per share.

Mana Capital Acquisition Corp. announced that for the purpose of consummating its previously announced business combination with Cardio Diagnostics, Inc., the Company has extended the date by which it is required to complete a business combination for an additional period of one month from August 26, 2022 to September 26, 2022, and that the amount of $216,667 has been deposited into the Company’s trust account in connection with the extension.

Jaguar Health, Inc. today announced that the Company has entered into a royalty interest purchase agreement with Utah-based Streeterville Capital, LLC (“Streeterville”).

Orthopedic Surgeon Cesar E. Ceballos, MD, FAAOS, Founder of OrthoMiami in Miami, Florida, announced a successful surgical intervention in a 19-year-old male using the FDA-cleared BEAR® Implant, manufactured by Miach Orthopedics, to repair an anterior cruciate ligament tear without necessity of a live or donor tendon graft.

AVM Biotechnology today announced the award of a third Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute (NCI).

Fresenius Medical Care North America’s (FMCNA) Renal Therapies Group today announced the availability of Speedswap ® , a new option for the NxStage ® System One ™ with NxView ™ that enables the changing of a flow-compromised dialysis filter without replacing the entire cartridge.

Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announced it has raised $10M in Series B funding led by VCapital.

Benchling, the R&D Cloud powering the biotechnology industry, announced the appointment of new executive leadership to its engineering and field organizations.

PathAI, a global leader in AI-powered pathology, today announced a multi-year expanded collaboration agreement with Bristol Myers Squibb.

TandemAI today announced the appointment of Steve Swann, Ph.D., to the newly created position of Chief Scientific Officer.